University of California San Francisco

Publications

  1. Robotic-assisted trans-mesocolic side-to-side duodenojejunostomy for palliative management of malignant distal duodenal obstruction.
    Yin H, Sharma D, Wang JJ, Ganjouei AA, Kouanda A, Hirose K, Nakakura E, Kirkwood K, Corvera C, Alseidi A, Adam MA
    Chin Clin Oncol. 2025 Feb; 14(1):5.; 
    PubMed
  2. Factors associated with grade progression in pancreatic neuroendocrine tumors.
    Wang SJ, Kidder W, Joseph NM, Le BK, Lindsay S, Moon F, Nakakura EK, Zhang L, Bergsland EK
    Endocr Relat Cancer. 2025 Mar 01; 32(3).; 
    PubMed
  3. Ongoing Failure to Deliver Guideline-Concordant Care for Patients with Pancreatic Cancer.
    Ejie J, Ashraf Ganjouei A, Hernandez S, Wang JJ, Romero-Hernandez F, Foroutani L, Hirose K, Nakakura E, Corvera CU, Alseidi A, Adam MA
    Cancers (Basel). 2025 Jan 07; 17(2).; 
    PubMed
  4. ASO Visual Abstract: Distinct Indications for Adjuvant Therapy in Resected Invasive Mucinous Cystic Neoplasms of the Pancreas Compared with Pancreatic Ductal Adenocarcinoma.
    Wong P, Pollini T, Adam MA, Alseidi A, Corvera CU, Hirose K, Kirkwood KS, Nakakura EK, Thornblade L, Maker AV
    Ann Surg Oncol. 2025 Jan; 32(1):536.; 
    PubMed
  5. Adult Pancreatoblastoma: Clinical Insights and Outcomes Compared to Pancreatic Ductal Adenocarcinoma (PDAC).
    Yin H, Romero-Hernandez F, Ganjouei AA, Wang JJ, Brown A, Hirose K, Maker AV, Nakakura E, Corvera C, Kirkwood KS, Wilhelm A, Peng JS, Alseidi A, Adam MA
    Curr Oncol. 2024 08 28; 31(9):5008-5020.; 
    PubMed
  6. Graft choice in pancreatectomy with vascular resection: equivalent safety in selected patients.
    Hoffman D, Ganjouei AA, Hernandez FR, Ifuku K, Miller P, Glencer A, Corvera C, Kirkwood K, Alseidi A, Adam M, Maker A, Hirose K, Hirose R, Nakakura EK
    J Gastrointest Surg. 2024 Nov; 28(11):1799-1804.; 
    PubMed
  7. ASO Visual Abstract: Long-Duration Neoadjuvant Therapy with FOLFIRINOX Yields Favorable Outcomes for Patients Who Undergo Surgery for Pancreatic Cancer.
    Miller PN, Romero-Hernandez F, Calthorpe L, Wang JJ, Kim SS, Corvera CU, Hirose K, Kirkwood KS, Hirose R, Maker AV, Alseidi AA, Adam MA, Kim GE, Tempero MA, Ko AH, Nakakura EK
    PubMed
  8. Distinct Indications for Adjuvant Therapy in Resected Invasive Mucinous Cystic Neoplasms of the Pancreas Compared with Pancreatic Ductal Adenocarcinoma.
    Wong P, Pollini T, Adam MA, Alseidi A, Corvera CU, Hirose K, Kirkwood KS, Nakakura EK, Thornblade L, Maker AV
    Ann Surg Oncol. 2024 Nov; 31(12):8276-8286.; 
    PubMed
  9. Enucleation of Neuroendocrine Liver Metastases.
    Yogo A, Kasai Y, Nakakura EK
    J Gastrointest Surg. 2024 Oct; 28(10):1735-1737.; 
    PubMed
  10. Minimal Residual Disease using a Plasma-Only Circulating Tumor DNA Assay to Predict Recurrence of Metastatic Colorectal Cancer Following Curative Intent Treatment.
    Parikh AR, Chee BH, Tsai J, Rich TA, Price KS, Patel SA, Zhang L, Ibrahim F, Esquivel M, Van Seventer EE, Jarnagin JX, Raymond VM, Corvera CU, Hirose K, Nakakura EK, Corcoran RB, Van Loon K, Atreya CE
    Clin Cancer Res. 2024 Jul 15; 30(14):2964-2973.; 
    PubMed
  11. ASO Author Reflections: Total Neoadjuvant Therapy with Chemotherapy Alone for Pancreatic Cancer?
    Miller PN, Nakakura EK
    Ann Surg Oncol. 2024 Sep; 31(9):6203-6204.; 
    PubMed
  12. Long-Duration Neoadjuvant Therapy with FOLFIRINOX Yields Favorable Outcomes for Patients Who Undergo Surgery for Pancreatic Cancer.
    Miller PN, Romero-Hernandez F, Calthorpe L, Wang JJ, Kim SS, Corvera CU, Hirose K, Kirkwood KS, Hirose R, Maker AV, Alseidi AA, Adam MA, Kim GE, Tempero MA, Ko AH, Nakakura EK
    Ann Surg Oncol. 2024 Sep; 31(9):6147-6156.; 
    PubMed
  13. ASO Author Reflections: Minimally Invasive Surgery for Prototypical Small Intestinal Neuroendocrine Tumors.
    Yogo A, Nakakura EK
    Ann Surg Oncol. 2024 Sep; 31(9):5537-5538.; 
    PubMed
  14. Long-Term Survival Outcomes After Minimally Invasive Surgery for Ileal Neuroendocrine Tumors.
    Yogo A, Paciorek A, Kasai Y, Moon F, Hirose K, Corvera CU, Bergsland EK, Nakakura EK
    Ann Surg Oncol. 2024 Sep; 31(9):5507-5514.; 
    PubMed
  15. National practice patterns in the use of endoscopic ultrasound biopsy for resectable Pancreatic Neuroendocrine Tumors: Insights into the role of DOTATATE PET/CT in diagnosis.
    Casey M, Brown A, Romero-Hernandez F, Wang JJ, Ganjouei AA, Tozzi F, Rashidian N, Kirkwood K, Corvera C, Nakakura E, Alseidi A, Adam M
    Am J Surg. 2024 Sep; 235:115779.; 
    PubMed
  16. Metastatic melanoma to small bowel: metastasectomy is supported in the era of immunotherapy and checkpoint inhibitors.
    Wong P, Wisneski AD, Tsai KK, Chang TT, Hirose K, Nakakura EK, Daud AI, Maker AV, Corvera CU
    World J Surg Oncol. 2024 Mar 11; 22(1):77.; 
    PubMed
  17. Robotic-assisted endoluminal gastric leiomyoma resection: a novel surgical technique for benign gastroesophageal junction tumors.
    Yin H, Ganjouei AA, Wang JJ, Romero-Hernandez F, Nakakura E, Alseidi A, Adam MA
    Chin Clin Oncol. 2024 Feb; 13(1):6.; 
    PubMed
  18. Improved survival of patients receiving immunotherapy and chemotherapy following curative-intent resection of colorectal liver metastases.
    Pollini T, Tran T, Wong P, Adam MA, Alseidi A, Corvera C, Hirose K, Nakakura E, Warren R, Maker VK, Maker AV
    J Gastrointest Surg. 2024 Mar; 28(3):246-251.; 
    PubMed
  19. A Machine Learning Approach to Predict Postoperative Pancreatic Fistula After Pancreaticoduodenectomy Using Only Preoperatively Known Data.
    Ashraf Ganjouei A, Romero-Hernandez F, Wang JJ, Casey M, Frye W, Hoffman D, Hirose K, Nakakura E, Corvera C, Maker AV, Kirkwood KS, Alseidi A, Adam MA
    Ann Surg Oncol. 2023 Nov; 30(12):7738-7747.; 
    PubMed
  20. ASO Visual Abstract: National Practice Patterns in Malignant Peritoneal Mesothelioma-Updates in Management and Survival.
    Calthorpe L, Romero-Hernandez F, Casey M, Nunez M, Conroy PC, Hirose K, Kim A, Kirkwood K, Maker AV, Corvera C, Nakakura E, Alseidi A, Adam MA
    Ann Surg Oncol. 2023 Aug; 30(8):5131.; 
    PubMed
  21. Expert Consensus Practice Recommendations of the North American Neuroendocrine Tumor Society for the management of high grade gastroenteropancreatic and gynecologic neuroendocrine neoplasms.
    Eads JR, Halfdanarson TR, Asmis T, Bellizzi AM, Bergsland EK, Dasari A, El-Haddad G, Frumovitz M, Meyer J, Mittra E, Myrehaug S, Nakakura E, Raj N, Soares HP, Untch B, Vijayvergia N, Chan JA
    Endocr Relat Cancer. 2023 08 01; 30(8).; 
    PubMed
  22. Residual Tumor Volume, Not Percent Cytoreduction, Matters for Surgery of Neuroendocrine Liver Metastasis.
    Kasai Y, Nakakura EK, Yogo A, Nagai K, Masui T, Hatano E
    Ann Surg Oncol. 2023 09; 30(9):5457-5458.; 
    PubMed
  23. Ampullary Adenocarcinoma, Version 1.2023, NCCN Clinical Practice Guidelines in Oncology.
    Chiorean EG, Chiaro MD, Tempero MA, Malafa MP, Benson AB, Cardin DB, Christensen JA, Chung V, Czito B, Dillhoff M, Donahue TR, Dotan E, Fountzilas C, Glazer ES, Hardacre J, Hawkins WG, Klute K, Ko AH, Kunstman JW, LoConte N, Lowy AM, Masood A, Moravek C, Nakakura EK, Narang AK, Nardo L, Obando J, Polanco PM, Reddy S, Reyngold M, Scaife C, Shen J, Truty MJ, Vollmer C, Wolff RA, Wolpin BM, Rn BM, Lubin S, Darlow SD
    J Natl Compr Canc Netw. 2023 07; 21(7):753-782.; 
    PubMed
  24. National Practice Patterns in Malignant Peritoneal Mesothelioma: Updates in Management and Survival.
    Calthorpe L, Romero-Hernandez F, Casey M, Nunez M, Conroy PC, Hirose K, Kim A, Kirkwood K, Maker AV, Corvera C, Nakakura E, Alseidi A, Adam MA
    Ann Surg Oncol. 2023 Aug; 30(8):5119-5129.; 
    PubMed
  25. Laparoscopic Gastrectomy for Gastric Cancer.
    Hoffman DB, Nakakura EK
    JAMA Surg. 2023 05 01; 158(5):454-455.; 
    PubMed
  26. Metastatic colorectal adenocarcinoma tumor purity assessment from whole exome sequencing data.
    Tbeileh N, Timmerman L, Mattis AN, Toriguchi K, Kasai Y, Corvera C, Nakakura E, Hirose K, Donner DB, Warren RS, Karelehto E
    PLoS One. 2023; 18(4):e0271354.; 
    PubMed
  27. Baseline tumor growth rate highlights the heterogeneity of well differentiated gastroenteropancreatic neuroendocrine tumors and predicts for increases in Ki67 index over time.
    Wang SJ, Whitman J, Paciorek A, Le BK, Nakakura EK, Behr SC, Joseph N, Zhang L, Hope TA, Bergsland EK
    J Neuroendocrinol. 2023 04; 35(4):e13260.; 
    PubMed
  28. Hypertension Requiring Medication Use: a Silent Predictor of Poor Outcomes After Pancreaticoduodenectomy.
    Lin JJ, Conroy PC, Romero-Hernandez F, Yilma M, Feng J, Hirose K, Nakakura E, Maker AV, Corvera C, Kirkwood K, Alseidi A, Adam MA
    J Gastrointest Surg. 2023 02; 27(2):328-336.; 
    PubMed
  29. Contemporary Trends in Malignant Peritoneal Mesothelioma: Incidence and Survival in the United States.
    Calthorpe L, Romero-Hernandez F, Miller P, Conroy PC, Hirose K, Kim A, Kirkwood K, Nakakura E, Corvera C, Maker AV, Alseidi A, Adam MA
    Cancers (Basel). 2022 Dec 30; 15(1).; 
    PubMed
  30. Hand-Assisted Versus Pure Minimally-Invasive Distal Pancreatectomy: Is There a Downside to Lending a Hand?
    Miller PN, Romero-Hernandez F, Conroy P, Calthorpe L, Yilma M, Mohamedaly S, Kelly YM, Feng J, Hirose K, Kirkwood K, Maker AV, Corvera C, Nakakura E, Alseidi A, Adam MA
    World J Surg. 2023 03; 47(3):750-758.; 
    PubMed
  31. Minimally Invasive Distal Pancreatectomy Techniques: A Contemporary Analysis Exploring Trends, Similarities, and Differences to Open Surgery.
    Romero-Hernandez F, Mohamedaly S, Miller P, Rodriguez N, Calthorpe L, Conroy PC, Ganjouei AA, Hirose K, Maker AV, Nakakura E, Corvera C, Kirkwood KS, Alseidi A, Adam MA
    Cancers (Basel). 2022 Nov 16; 14(22).; 
    PubMed
  32. Whole genome sequencing reveals the independent clonal origin of multifocal ileal neuroendocrine tumors.
    Mäkinen N, Zhou M, Zhang Z, Kasai Y, Perez E, Kim GE, Thirlwell C, Nakakura E, Meyerson M
    Genome Med. 2022 08 03; 14(1):82.; 
    PubMed
  33. ASO Visual Abstract: Determining Hospital Volume Threshold for the Safety of Minimally Invasive Pancreaticoduodenectomy: A Contemporary Cutpoint Analysis.
    Conroy PC, Calthorpe L, Lin JA, Mohamedaly S, Kim A, Hirose K, Nakakura E, Corvera C, Sosa JA, Sarin A, Kirkwood KS, Alseidi A, Adam MA
    Ann Surg Oncol. 2022 Jan 15.; 
    PubMed
  34. Optimal Staging for Gastric Cancer Starts With High-Resolution Computed Tomography.
    Brown AE, Nakakura EK
    JAMA Surg. 2021 12 01; 156(12):e215330.; 
    PubMed
  35. Determining Hospital Volume Threshold for Safety of Minimally Invasive Pancreaticoduodenectomy: A Contemporary Cutpoint Analysis.
    Conroy PC, Calthorpe L, Lin JA, Mohamedaly S, Kim A, Hirose K, Nakakura E, Corvera C, Sosa JA, Sarin A, Kirkwood KS, Alseidi A, Adam MA
    Ann Surg Oncol. 2022 Mar; 29(3):1566-1574.; 
    PubMed
  36. Preoperative risk stratification of lymph node metastasis for non-functional pancreatic neuroendocrine neoplasm: An international dual-institutional study.
    Kasai Y, Masui T, Nakakura EK, Nakano K, Sato A, Uchida Y, Yogo A, Nagai K, Anazawa T, Hope TA, Kim GE, Whitman J, Le BK, Takaori K, Bergsland EK, Hatano E, Uemoto S
    Pancreatology. 2022 Jan; 22(1):123-129.; 
    PubMed
  37. Evidence-Based Guidelines for Branch-Duct Intraductal Papillary Mucinous Neoplasm Management: Still a Lot of Room to Grow.
    Conroy PC, Nakakura E
    JAMA Surg. 2021 07 01; 156(7):661-662.; 
    PubMed
  38. Outcomes after high-dose radiation in the management of neuroendocrine neoplasms.
    Chen KS, Lawhn-Heath C, Behr S, Juarez R, Whitman J, Paciorek A, Nakakura EK, Fidelman N, Feng MU, Bergsland EK, Anwar M
    PLoS One. 2021; 16(6):e0252574.; 
    PubMed
  39. Burden of Ionizing Radiation in the Diagnosis and Management of Necrotizing Pancreatitis.
    Thiruvengadam NR, Miranda J, Kim C, Behr S, Corvera C, Dai SC, Kirkwood K, Harris HW, Hirose K, Nakakura E, Ostroff JW, Kochman ML, Arain MA
    Clin Transl Gastroenterol. 2021 04 27; 12(5):e00347.; 
    PubMed
  40. Pancreatic Adenocarcinoma, Version 2.2021, NCCN Clinical Practice Guidelines in Oncology.
    Tempero MA, Malafa MP, Al-Hawary M, Behrman SW, Benson AB, Cardin DB, Chiorean EG, Chung V, Czito B, Del Chiaro M, Dillhoff M, Donahue TR, Dotan E, Ferrone CR, Fountzilas C, Hardacre J, Hawkins WG, Klute K, Ko AH, Kunstman JW, LoConte N, Lowy AM, Moravek C, Nakakura EK, Narang AK, Obando J, Polanco PM, Reddy S, Reyngold M, Scaife C, Shen J, Vollmer C, Wolff RA, Wolpin BM, Lynn B, George GV
    J Natl Compr Canc Netw. 2021 04 01; 19(4):439-457.; 
    PubMed
  41. Recurrence Patterns After Surgical Resection of Gastroenteropancreatic Neuroendocrine Tumors: Analysis From the National Comprehensive Cancer Network Oncology Outcomes Database.
    Chan H, Zhang L, Choti MA, Kulke M, Yao JC, Nakakura EK, Bloomston M, Benson AB, Shah MH, Strosberg JR, Bergsland EK, Van Loon K
    Pancreas. 2021 04 01; 50(4):506-512.; 
    PubMed
  42. Minimally Invasive Surgery for Ileal Neuroendocrine Tumors.
    Mahuron KM, Kasai Y, Javeed ZA, Bergsland EK, Hirose K, Corvera CU, Nakakura EK
    J Gastrointest Surg. 2021 11; 25(11):2954-2956.; 
    PubMed
  43. Contemporary Management of Hepatic Cyst Disease: Techniques and Outcomes at a Tertiary Hepatobiliary Center.
    Gomez A, Wisneski AD, Luu HY, Hirose K, Roberts JP, Hirose R, Freise CE, Nakakura EK, Corvera CU
    J Gastrointest Surg. 2021 01; 25(1):77-84.; 
    PubMed
  44. Hybrid Low-Grade Fibromyxoid Sarcoma and Sclerosing Epithelioid Fibrosarcoma of the Pancreas.
    Kramer SP, Bowman CJ, Wang ZJ, Sheahon KM, Nakakura EK, Cho SJ, Umetsu SE, Behr SC
    J Gastrointest Cancer. 2020 Sep; 51(3):1025-1029.; 
    PubMed
  45. Randomized Clinical Trial of Nasogastric Tube Placement After Pancreaticoduodenectomy.
    Sharib JM, Nakakura EK
    JAMA Surg. 2020 09 01; 155(9):e202305.; 
    PubMed
  46. Synchronous Versus Metachronous Colorectal Liver Metastasis Yields Similar Survival in Modern Era.
    Wisneski AD, Jin C, Huang CY, Warren R, Hirose K, Nakakura EK, Corvera CU
    J Surg Res. 2020 12; 256:476-485.; 
    PubMed
  47. Awareness of a mesenteric mass as a common manifestation of ileal neuroendocrine tumor.
    Kasai Y, Nakakura EK
    Surg Case Rep. 2020 May 24; 6(1):110.; 
    PubMed
  48. Patterns of chromosome 18 loss of heterozygosity in multifocal ileal neuroendocrine tumors.
    Zhang Z, Mäkinen N, Kasai Y, Kim GE, Diosdado B, Nakakura E, Meyerson M
    Genes Chromosomes Cancer. 2020 09; 59(9):535-539.; 
    PubMed
  49. Ampullary stenosis and choledocholithiasis post Roux-En-Y gastric bypass: challenges of biliary access and intervention.
    Wisneski AD, Carter J, Nakakura EK, Posselt A, Rogers SJ, Cello JP, Arain M, Kirkwood KS, Hirose K, Stewart L, Corvera CU
    HPB (Oxford). 2020 10; 22(10):1496-1503.; 
    PubMed
  50. A novel stratification of mesenteric mass involvement as a predictor of challenging mesenteric lymph node dissection by minimally invasive approach for ileal neuroendocrine tumors.
    Kasai Y, Mahuron K, Hirose K, Corvera CU, Kim GE, Hope TA, Shih BE, Warren RS, Bergsland EK, Nakakura EK
    J Surg Oncol. 2020 Aug; 122(2):204-211.; 
    PubMed
  51. Residual tumor volume discriminates prognosis after surgery for neuroendocrine liver metastasis.
    Kasai Y, Hirose K, Corvera CU, Kim GE, Hope TA, Shih BE, Harun N, Kim MO, Warren RS, Bergsland EK, Nakakura EK
    J Surg Oncol. 2020 Feb; 121(2):330-336.; 
    PubMed
  52. Prognostic impact of a large mesenteric mass >2 cm in ileal neuroendocrine tumors.
    Kasai Y, Mahuron K, Hirose K, Corvera CU, Kim GE, Hope TA, Shih BE, Warren RS, Bergsland EK, Nakakura EK
    J Surg Oncol. 2019 Dec; 120(8):1311-1317.; 
    PubMed
  53. Adjuvant Therapy for Ampullary Cancer.
    Ko AH, Nakakura EK
    JAMA Surg. 2019 08 01; 154(8):715.; 
    PubMed
  54. High thymidylate synthase gene expression predicts poor outcome after resection of hepatocellular carcinoma.
    Donner DB, Nakakura EK, Venook AP, Lenz HJ, Zhang W, Hwang J, Bergsland EK, Lin MH, Toriguchi K, Antonia RJ, Warren RS
    PLoS One. 2019; 14(7):e0219469.; 
    PubMed
  55. Periprocedural Management of Patients Undergoing Liver Resection or Embolotherapy for Neuroendocrine Tumor Metastases.
    Kwon DH, Paciorek A, Mulvey CK, Chan H, Fidelman N, Meng L, Nakakura EK, Zhang L, Bergsland EK, Van Loon K
    Pancreas. 2019 04; 48(4):496-503.; 
    PubMed
  56. Comparison of Tumor Regression Grading of Residual Pancreatic Ductal Adenocarcinoma Following Neoadjuvant Chemotherapy Without Radiation: Would Fewer Tier-Stratification Be Favorable Toward Standardization?
    Kim SS, Ko AH, Nakakura EK, Wang ZJ, Corvera CU, Harris HW, Kirkwood KS, Hirose R, Tempero MA, Kim GE
    Am J Surg Pathol. 2019 03; 43(3):334-340.; 
    PubMed
  57. Pancreatic Adenocarcinoma, Version 1.2019.
    Tempero MA, Malafa MP, Chiorean EG, Czito B, Scaife C, Narang AK, Fountzilas C, Wolpin BM, Al-Hawary M, Asbun H, Behrman SW, Benson AB, Binder E, Cardin DB, Cha C, Chung V, Dillhoff M, Dotan E, Ferrone CR, Fisher G, Hardacre J, Hawkins WG, Ko AH, LoConte N, Lowy AM, Moravek C, Nakakura EK, O'Reilly EM, Obando J, Reddy S, Thayer S, Wolff RA, Burns JL, Zuccarino-Catania G
    J Natl Compr Canc Netw. 2019 03 01; 17(3):202-210.; 
    PubMed
  58. Mitogen Inducible Gene-6 Is a Prognostic Marker for Patients with Colorectal Liver Metastases.
    Donner DB, Ruan DT, Toriguchi K, Bergsland EK, Nakakura EK, Lin MH, Antonia RJ, Warren RS
    Transl Oncol. 2019 Mar; 12(3):550-560.; 
    PubMed
  59. A Patient-derived Xenograft Model of Pancreatic Neuroendocrine Tumors Identifies Sapanisertib as a Possible New Treatment for Everolimus-resistant Tumors.
    Chamberlain CE, German MS, Yang K, Wang J, VanBrocklin H, Regan M, Shokat KM, Ducker GS, Kim GE, Hann B, Donner DB, Warren RS, Venook AP, Bergsland EK, Lee D, Wang Y, Nakakura EK
    Mol Cancer Ther. 2018 12; 17(12):2702-2709.; 
    PubMed
  60. Outcomes of arterial bypass preceding resection of retroperitoneal masses involving major vessels.
    Luu HY, Wang ED, Syed SM, Xu X, Hansen SL, Eichler CM, Nakakura EK
    J Surg Res. 2018 10; 230:34-39.; 
    PubMed
  61. Progress in the March to Precision Cancer Medicine: Left, Right, Left.
    Nakakura EK
    JAMA Surg. 2018 01 01; 153(1):67-68.; 
    PubMed
  62. Challenges Staging Neuroendocrine Tumors of the Pancreas, Jejunum and Ileum, and Appendix.
    Nakakura EK
    Ann Surg Oncol. 2018 Mar; 25(3):591-593.; 
    PubMed
  63. Pancreatic Adenocarcinoma, Version 2.2017, NCCN Clinical Practice Guidelines in Oncology.
    Tempero MA, Malafa MP, Al-Hawary M, Asbun H, Bain A, Behrman SW, Benson AB, Binder E, Cardin DB, Cha C, Chiorean EG, Chung V, Czito B, Dillhoff M, Dotan E, Ferrone CR, Hardacre J, Hawkins WG, Herman J, Ko AH, Komanduri S, Koong A, LoConte N, Lowy AM, Moravek C, Nakakura EK, O'Reilly EM, Obando J, Reddy S, Scaife C, Thayer S, Weekes CD, Wolff RA, Wolpin BM, Burns J, Darlow S
    J Natl Compr Canc Netw. 2017 08; 15(8):1028-1061.; 
    PubMed
  64. Gastrocutaneous Fistula in a Patient with Locally Recurrent MSI-High Colorectal Cancer: Local Complications Arising from Therapeutic Response to Immune Checkpoint Blockade.
    Greene C, Nakakura EK, Ko AH
    Anticancer Res. 2017 07; 37(7):3679-3684.; 
    PubMed
  65. The Surgical Management of Small Bowel Neuroendocrine Tumors: Consensus Guidelines of the North American Neuroendocrine Tumor Society.
    Howe JR, Cardona K, Fraker DL, Kebebew E, Untch BR, Wang YZ, Law CH, Liu EH, Kim MK, Menda Y, Morse BG, Bergsland EK, Strosberg JR, Nakakura EK, Pommier RF
    Pancreas. 2017 07; 46(6):715-731.; 
    PubMed
  66. Complicated Case Presentation: Management of Pancreatic Neuroendocrine Tumors in Multiple Endocrine Neoplasia Type 1.
    Mulvey CK, Van Loon K, Bergsland EK, Masharani U, Nakakura EK
    Pancreas. 2017 03; 46(3):416-426.; 
    PubMed
  67. Preoperative FOLFIRINOX for borderline resectable pancreatic cancer: Is radiation necessary in the modern era of chemotherapy?
    Kim SS, Nakakura EK, Wang ZJ, Kim GE, Corvera CU, Harris HW, Kirkwood KS, Hirose R, Tempero MA, Ko AH
    J Surg Oncol. 2016 Oct; 114(5):587-596.; 
    PubMed
  68. Finding the Common Thread in Rare Diseases.
    Nakakura EK
    JAMA Surg. 2016 Apr; 151(4):355.; 
    PubMed
  69. Correcting for respiratory motion in liver PET/MRI: preliminary evaluation of the utility of bellows and navigated hepatobiliary phase imaging.
    Hope TA, Verdin EF, Bergsland EK, Ohliger MA, Corvera CU, Nakakura EK
    EJNMMI Phys. 2015 Dec; 2(1):21.; 
    PubMed
  70. Solid pseudopapillary neoplasm of the pancreas head in a pregnant woman: safe pancreaticoduodenectomy postpartum.
    Yee AM, Kelly BG, Gonzalez-Velez JM, Nakakura EK
    J Surg Case Rep. 2015 Aug 20; 2015(8).; 
    PubMed
  71. Simultaneous (68)Ga-DOTA-TOC PET/MRI with gadoxetate disodium in patients with neuroendocrine tumor.
    Hope TA, Pampaloni MH, Nakakura E, VanBrocklin H, Slater J, Jivan S, Aparici CM, Yee J, Bergsland E
    Abdom Imaging. 2015 Aug; 40(6):1432-40.; 
    PubMed
  72. A patient with cholangiocarcinoma demonstrating pathologic complete response to chemotherapy: exploring the role of neoadjuvant therapy in biliary tract cancer.
    Walker EJ, Simko JP, Nakakura EK, Ko AH
    J Gastrointest Oncol. 2014 Dec; 5(6):E88-95.; 
    PubMed
  73. Bone metastases and skeletal-related events from neuroendocrine tumors.
    Van Loon K, Zhang L, Keiser J, Carrasco C, Glass K, Ramirez MT, Bobiak S, Nakakura EK, Venook AP, Shah MH, Bergsland EK
    Endocr Connect. 2015 Mar; 4(1):9-17.; 
    PubMed
  74. Neuroendocrine tumors of unknown primary: is the primary site really not known?
    Bergsland EK, Nakakura EK
    JAMA Surg. 2014 Sep; 149(9):889-90.; 
    PubMed
  75. Pancreatic adenocarcinoma, version 2.2014: featured updates to the NCCN guidelines.
    Tempero MA, Malafa MP, Behrman SW, Benson AB, Casper ES, Chiorean EG, Chung V, Cohen SJ, Czito B, Engebretson A, Feng M, Hawkins WG, Herman J, Hoffman JP, Ko A, Komanduri S, Koong A, Lowy AM, Ma WW, Merchant NB, Mulvihill SJ, Muscarella P, Nakakura EK, Obando J, Pitman MB, Reddy S, Sasson AR, Thayer SP, Weekes CD, Wolff RA, Wolpin BM, Burns JL, Freedman-Cass DA
    J Natl Compr Canc Netw. 2014 Aug; 12(8):1083-93.; 
    PubMed
  76. Time to put another surgical dogma to sleep?
    Nakakura EK
    JAMA Surg. 2014 May; 149(5):466.; 
    PubMed
  77. Home, sweet home, after surgery.
    Nakakura EK
    JAMA Surg. 2014 Mar; 149(3):251.; 
    PubMed
  78. Incomplete inhibition of phosphorylation of 4E-BP1 as a mechanism of primary resistance to ATP-competitive mTOR inhibitors.
    Ducker GS, Atreya CE, Simko JP, Hom YK, Matli MR, Benes CH, Hann B, Nakakura EK, Bergsland EK, Donner DB, Settleman J, Shokat KM, Warren RS
    Oncogene. 2014 Mar 20; 33(12):1590-600.; 
    PubMed
  79. Management of well-differentiated gastrointestinal neuroendocrine tumors metastatic to the liver.
    Wang SC, Fidelman N, Nakakura EK
    Semin Oncol. 2013 Feb; 40(1):69-74.; 
    PubMed
  80. Reply to P.H. Sugarbaker.
    Nakakura EK
    J Clin Oncol. 2013 Jan 20; 31(3):397-8.; 
    PubMed
  81. Can CT features differentiate between inferior vena cava leiomyosarcomas and primary retroperitoneal masses?
    Webb EM, Wang ZJ, Westphalen AC, Nakakura EK, Coakley FV, Yeh BM
    AJR Am J Roentgenol. 2013 Jan; 200(1):205-9.; 
    PubMed
  82. Lymph node sampling rates and predictors of nodal metastasis in pancreatic neuroendocrine tumor resections: the UCSF experience with 149 patients.
    Parekh JR, Wang SC, Bergsland EK, Venook AP, Warren RS, Kim GE, Nakakura EK
    Pancreas. 2012 Aug; 41(6):840-4.; 
    PubMed
  83. Pancreatic Adenocarcinoma, version 2.2012: featured updates to the NCCN Guidelines.
    Tempero MA, Arnoletti JP, Behrman SW, Ben-Josef E, Benson AB, Casper ES, Cohen SJ, Czito B, Ellenhorn JD, Hawkins WG, Herman J, Hoffman JP, Ko A, Komanduri S, Koong A, Ma WW, Malafa MP, Merchant NB, Mulvihill SJ, Muscarella P, Nakakura EK, Obando J, Pitman MB, Sasson AR, Tally A, Thayer SP, Whiting S, Wolff RA, Wolpin BM, Freedman-Cass DA, Shead DA, National Comprehensive Cancer Networks
    J Natl Compr Canc Netw. 2012 Jun 01; 10(6):703-13.; 
    PubMed
  84. Pseudomyxoma peritonei: more questions than answers.
    Nakakura EK
    J Clin Oncol. 2012 Jul 10; 30(20):2429-30.; 
    PubMed
  85. Complete and safe resection of challenging retroperitoneal tumors: anticipation of multi-organ and major vascular resection and use of adjunct procedures.
    Tseng WW, Wang SC, Eichler CM, Warren RS, Nakakura EK
    World J Surg Oncol. 2011 Nov 04; 9:143.; 
    PubMed
  86. Unique patterns of metastases in common and rare types of malignancy.
    Leong SP, Nakakura EK, Pollock R, Choti MA, Morton DL, Henner WD, Lal A, Pillai R, Clark OH, Cady B
    J Surg Oncol. 2011 May 01; 103(6):607-14.; 
    PubMed
  87. Pancreatic adenocarcinoma.
    Tempero MA, Arnoletti JP, Behrman S, Ben-Josef E, Benson AB, Berlin JD, Cameron JL, Casper ES, Cohen SJ, Duff M, Ellenhorn JD, Hawkins WG, Hoffman JP, Kuvshinoff BW, Malafa MP, Muscarella P, Nakakura EK, Sasson AR, Thayer SP, Tyler DS, Warren RS, Whiting S, Willett C, Wolff RA, NCCN Pancreatic Adenocarcinoma
    J Natl Compr Canc Netw. 2010 Sep; 8(9):972-1017.; 
    PubMed
  88. Lack of NKX2.2 expression in bronchopulmonary typical carcinoid tumors: implications for patients with neuroendocrine tumor metastases and unknown primary site.
    Wang YC, Iezza G, Zuraek MB, Jablons DM, Theodore PR, Bergsland EK, Donner DB, Warren RS, Nakakura EK
    J Surg Res. 2010 Sep; 163(1):47-51.; 
    PubMed
  89. Arterial embolization for the management of gastrointestinal hemorrhage from metastatic renal cell carcinoma.
    Fidelman N, Freed RC, Nakakura EK, Rosenberg J, Bloom AI
    J Vasc Interv Radiol. 2010 May; 21(5):741-4.; 
    PubMed
  90. Identification of unknown primary tumors in patients with neuroendocrine liver metastases.
    Wang SC, Parekh JR, Zuraek MB, Venook AP, Bergsland EK, Warren RS, Nakakura EK
    Arch Surg. 2010 Mar; 145(3):276-80.; 
    PubMed
  91. The ETS oncogene family transcription factor FEV identifies serotonin-producing cells in normal and neoplastic small intestine.
    Wang YC, Zuraek MB, Kosaka Y, Ota Y, German MS, Deneris ES, Bergsland EK, Donner DB, Warren RS, Nakakura EK
    Endocr Relat Cancer. 2010 Mar; 17(1):283-91.; 
    PubMed
  92. MicroRNA dynamics in the stages of tumorigenesis correlate with hallmark capabilities of cancer.
    Olson P, Lu J, Zhang H, Shai A, Chun MG, Wang Y, Libutti SK, Nakakura EK, Golub TR, Hanahan D
    Genes Dev. 2009 Sep 15; 23(18):2152-65.; 
    PubMed
  93. Mitogen-inducible gene-6 expression correlates with survival and is an independent predictor of recurrence in BRAF(V600E) positive papillary thyroid cancers.
    Ruan DT, Warren RS, Moalem J, Chung KW, Griffin AC, Shen W, Duh QY, Nakakura E, Donner DB, Khanafshar E, Weng J, Clark OH, Kebebew E
    Surgery. 2008 Dec; 144(6):908-13; discussion 913-4.; 
    PubMed
  94. Homeodomain transcription factor NKX2.2 functions in immature cells to control enteroendocrine differentiation and is expressed in gastrointestinal neuroendocrine tumors.
    Wang YC, Gallego-Arteche E, Iezza G, Yuan X, Matli MR, Choo SP, Zuraek MB, Gogia R, Lynn FC, German MS, Bergsland EK, Donner DB, Warren RS, Nakakura EK
    Endocr Relat Cancer. 2009 Mar; 16(1):267-79.; 
    PubMed
  95. Compound muscle action potentials and spontaneous electromyography can be used to identify and protect the femoral nerve during resection of large retroperitoneal tumors.
    Guo L, Clark JP, Warren RS, Nakakura EK
    Ann Surg Oncol. 2008 Jun; 15(6):1594-9.; 
    PubMed
  96. Immunostaining for peroxisome proliferator gamma distinguishes dedifferentiated liposarcoma from other retroperitoneal sarcomas.
    Horvai AE, Schaefer JT, Nakakura EK, O'Donnell RJ
    Mod Pathol. 2008 May; 21(5):517-24.; 
    PubMed
  97. Introduction.
    Warren RS, Nakakura EK
    Surg Oncol. 2007 Dec; 16(4):235.; 
    PubMed
  98. Pancreatic adenocarcinoma. Clinical Practice Guidelines in Oncology.
    Tempero M, Arnoletti JP, Ben-Josef E, Bhargava P, Casper ES, Kim P, Malafa MP, Nakakura EK, Shibata S, Talamonti M, Wang H, Willett C
    J Natl Compr Canc Netw. 2007 Nov; 5(10):998-1033.; 
    PubMed
  99. Palliative care for patients with advanced pancreatic and biliary cancers.
    Nakakura EK, Warren RS
    Surg Oncol. 2007 Dec; 16(4):293-7.; 
    PubMed
  100. Systemic and regional nonsurgical therapy--what is the optimal strategy for metastatic neuroendocrine cancer?
    Nakakura EK, Venook AP, Bergsland EK
    Surg Oncol Clin N Am. 2007 Jul; 16(3):639-51, x.; 
    PubMed
  101. Islet cell carcinoma: neuroendocrine tumors of the pancreas and periampullary region.
    Nakakura EK, Bergsland EK
    Hematol Oncol Clin North Am. 2007 Jun; 21(3):457-73; viii.; 
    PubMed
  102. Cyclin-dependent kinase 5 activity controls cell motility and metastatic potential of prostate cancer cells.
    Strock CJ, Park JI, Nakakura EK, Bova GS, Isaacs JT, Ball DW, Nelkin BD
    Cancer Res. 2006 Aug 01; 66(15):7509-15.; 
    PubMed
  103. Regulation of neuroendocrine differentiation in gastrointestinal carcinoid tumor cells by notch signaling.
    Nakakura EK, Sriuranpong VR, Kunnimalaiyaan M, Hsiao EC, Schuebel KE, Borges MW, Jin N, Collins BJ, Nelkin BD, Chen H, Ball DW
    J Clin Endocrinol Metab. 2005 Jul; 90(7):4350-6.; 
    PubMed
  104. Notch signaling induces rapid degradation of achaete-scute homolog 1.
    Sriuranpong V, Borges MW, Strock CL, Nakakura EK, Watkins DN, Blaumueller CM, Nelkin BD, Ball DW
    Mol Cell Biol. 2002 May; 22(9):3129-39.; 
    PubMed
  105. Mammalian Scratch participates in neuronal differentiation in P19 embryonal carcinoma cells.
    Nakakura EK, Watkins DN, Sriuranpong V, Borges MW, Nelkin BD, Ball DW
    Brain Res Mol Brain Res. 2001 Nov 01; 95(1-2):162-6.; 
    PubMed
  106. Mammalian Scratch: a neural-specific Snail family transcriptional repressor.
    Nakakura EK, Watkins DN, Schuebel KE, Sriuranpong V, Borges MW, Nelkin BD, Ball DW
    Proc Natl Acad Sci U S A. 2001 Mar 27; 98(7):4010-5.; 
    PubMed
  107. Management of hepatocellular carcinoma.
    Nakakura EK, Choti MA
    Oncology (Williston Park). 2000 Jul; 14(7):1085-98; discussion 1098-102.; 
    PubMed
  108. Long-term survival of solid organ allografts by brief anti-lymphocyte function-associated antigen-1 monoclonal antibody monotherapy.
    Nakakura EK, Shorthouse RA, Zheng B, McCabe SM, Jardieu PM, Morris RE
    Transplantation. 1996 Sep 15; 62(5):547-52.; 
    PubMed
  109. A non-lymphocyte-depleting monoclonal antibody to the adhesion molecule LFA-1 (CD11a) prevents sensitization to alloantigens and effectively prolongs the survival of heart allografts.
    Nakakura EK, McCabe SM, Zheng B, Shorthouse RA, Scheiner TM, Blank G, Jardieu PM, Morris RE
    Transplant Proc. 1993 Feb; 25(1 Pt 1):809-12.; 
    PubMed
  110. Potent and effective prolongation by anti-LFA-1 monoclonal antibody monotherapy of non-primarily vascularized heart allograft survival in mice without T cell depletion.
    Nakakura EK, McCabe SM, Zheng B, Shorthouse RA, Scheiner TM, Blank G, Jardieu PM, Morris RE
    Transplantation. 1993 Feb; 55(2):412-7.; 
    PubMed